United States Type 1 Diabetes Drugs Market Report 2017

United States Type 1 Diabetes Drugs Market Report 2017

1 Type 1 Diabetes Drugs Overview

1.1 Product Overview and Scope of Type 1 Diabetes Drugs

1.2 Classification of Type 1 Diabetes Drugs

1.2.1 Fast-Acting Insulin

1.2.2 Intermediate-Acting Insulin

1.2.3 Long-Acting Insulin

1.2.4 Other

1.3 Application of Type 1 Diabetes Drugs

1.3.1 Hospitals

1.3.2 Clinics

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Type 1 Diabetes Drugs (2012-2022)

1.4.1 United States Type 1 Diabetes Drugs Sales and Growth Rate (2012-2022)

1.4.2 United States Type 1 Diabetes Drugs Revenue and Growth Rate (2012-2022)

2 United States Type 1 Diabetes Drugs Competition by Manufacturers

2.1 United States Type 1 Diabetes Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Type 1 Diabetes Drugs Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Type 1 Diabetes Drugs Average Price by Manufactures (2015 and 2016)

2.4 Type 1 Diabetes Drugs Market Competitive Situation and Trends

2.4.1 Type 1 Diabetes Drugs Market Concentration Rate

2.4.2 Type 1 Diabetes Drugs Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Type 1 Diabetes Drugs Sales (Volume) and Revenue (Value) by States (2012-2017)

3.1 United States Type 1 Diabetes Drugs Sales and Market Share by States (2012-2017)

3.2 United States Type 1 Diabetes Drugs Revenue and Market Share by States (2012-2017)

3.3 United States Type 1 Diabetes Drugs Price by States (2012-2017)

4 United States Type 1 Diabetes Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)

4.1 United States Type 1 Diabetes Drugs Sales and Market Share by Type (2012-2017)

4.2 United States Type 1 Diabetes Drugs Revenue and Market Share by Type (2012-2017)

4.3 United States Type 1 Diabetes Drugs Price by Type (2012-2017)

4.4 United States Type 1 Diabetes Drugs Sales Growth Rate by Type (2012-2017)

5 United States Type 1 Diabetes Drugs Sales (Volume) by Application (2012-2017)

5.1 United States Type 1 Diabetes Drugs Sales and Market Share by Application (2012-2017)

5.2 United States Type 1 Diabetes Drugs Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Type 1 Diabetes Drugs Manufacturers Profiles/Analysis

6.1 Novo Nordisk

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Type 1 Diabetes Drugs Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Novo Nordisk Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Sanofi

6.2.2 Type 1 Diabetes Drugs Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Sanofi Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Eli Lily

6.3.2 Type 1 Diabetes Drugs Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Eli Lily Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 AstraZeneca

6.4.2 Type 1 Diabetes Drugs Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 AstraZeneca Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Astellas Pharma

6.5.2 Type 1 Diabetes Drugs Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Astellas Pharma Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Merck

6.6.2 Type 1 Diabetes Drugs Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Merck Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Perle Biosciences

6.7.2 Type 1 Diabetes Drugs Product Type, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Perle Biosciences Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Pfizer

6.8.2 Type 1 Diabetes Drugs Product Type, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Pfizer Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Merrion Pharmaceutical

6.9.2 Type 1 Diabetes Drugs Product Type, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Merrion Pharmaceutical Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Boehringer Ingelheim

6.10.2 Type 1 Diabetes Drugs Product Type, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Boehringer Ingelheim Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 XOMA

6.12 Osiris Therapeutics

6.13 GlaxoSmithKline

6.14 Generex Biotechnology

6.15 Gan & Lee Pharmaceuticals

6.16 Adocia

6.17 Baxalta

6.18 Tolerio

7 Type 1 Diabetes Drugs Manufacturing Cost Analysis

7.1 Type 1 Diabetes Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Type 1 Diabetes Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Type 1 Diabetes Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Type 1 Diabetes Drugs Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Type 1 Diabetes Drugs Market Forecast (2017-2022)

11.1 United States Type 1 Diabetes Drugs Sales, Revenue Forecast (2017-2022)

11.2 United States Type 1 Diabetes Drugs Sales Forecast by Type (2017-2022)

11.3 United States Type 1 Diabetes Drugs Sales Forecast by Application (2017-2022)

11.4 Type 1 Diabetes Drugs Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Type 1 Diabetes Drugs

Table Classification of Type 1 Diabetes Drugs

Figure United States Sales Market Share of Type 1 Diabetes Drugs by Type in 2015

Figure Fast-Acting Insulin Picture

Figure Intermediate-Acting Insulin Picture

Figure Long-Acting Insulin Picture

Figure Other Picture

Table Application of Type 1 Diabetes Drugs

Figure United States Sales Market Share of Type 1 Diabetes Drugs by Application in 2015

Figure Hospitals Examples

Figure Clinics Examples

Figure United States Type 1 Diabetes Drugs Sales and Growth Rate (2012-2022)

Figure United States Type 1 Diabetes Drugs Revenue and Growth Rate (2012-2022)

Table United States Type 1 Diabetes Drugs Sales of Key Manufacturers (2015 and 2016)

Table United States Type 1 Diabetes Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Type 1 Diabetes Drugs Sales Share by Manufacturers

Figure 2016 Type 1 Diabetes Drugs Sales Share by Manufacturers

Table United States Type 1 Diabetes Drugs Revenue by Manufacturers (2015 and 2016)

Table United States Type 1 Diabetes Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Type 1 Diabetes Drugs Revenue Share by Manufacturers

Table 2016 United States Type 1 Diabetes Drugs Revenue Share by Manufacturers

Table United States Market Type 1 Diabetes Drugs Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Type 1 Diabetes Drugs Average Price of Key Manufacturers in 2015

Figure Type 1 Diabetes Drugs Market Share of Top 3 Manufacturers

Figure Type 1 Diabetes Drugs Market Share of Top 5 Manufacturers

Table United States Type 1 Diabetes Drugs Sales by States (2012-2017)

Table United States Type 1 Diabetes Drugs Sales Share by States (2012-2017)

Figure United States Type 1 Diabetes Drugs Sales Market Share by States in 2015

Table United States Type 1 Diabetes Drugs Revenue and Market Share by States (2012-2017)

Table United States Type 1 Diabetes Drugs Revenue Share by States (2012-2017)

Figure Revenue Market Share of Type 1 Diabetes Drugs by States (2012-2017)

Table United States Type 1 Diabetes Drugs Price by States (2012-2017)

Table United States Type 1 Diabetes Drugs Sales by Type (2012-2017)

Table United States Type 1 Diabetes Drugs Sales Share by Type (2012-2017)

Figure United States Type 1 Diabetes Drugs Sales Market Share by Type in 2015

Table United States Type 1 Diabetes Drugs Revenue and Market Share by Type (2012-2017)

Table United States Type 1 Diabetes Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Type 1 Diabetes Drugs by Type (2012-2017)

Table United States Type 1 Diabetes Drugs Price by Type (2012-2017)

Figure United States Type 1 Diabetes Drugs Sales Growth Rate by Type (2012-2017)

Table United States Type 1 Diabetes Drugs Sales by Application (2012-2017)

Table United States Type 1 Diabetes Drugs Sales Market Share by Application (2012-2017)

Figure United States Type 1 Diabetes Drugs Sales Market Share by Application in 2015

Table United States Type 1 Diabetes Drugs Sales Growth Rate by Application (2012-2017)

Figure United States Type 1 Diabetes Drugs Sales Growth Rate by Application (2012-2017)

Table Novo Nordisk Basic Information List

Table Novo Nordisk Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Novo Nordisk Type 1 Diabetes Drugs Sales Market Share (2012-2017)

Table Sanofi Basic Information List

Table Sanofi Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Sanofi Type 1 Diabetes Drugs Sales Market Share (2012-2017)

Table Eli Lily Basic Information List

Table Eli Lily Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Eli Lily Type 1 Diabetes Drugs Sales Market Share (2012-2017)

Table AstraZeneca Basic Information List

Table AstraZeneca Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table AstraZeneca Type 1 Diabetes Drugs Sales Market Share (2012-2017)

Table Astellas Pharma Basic Information List

Table Astellas Pharma Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Astellas Pharma Type 1 Diabetes Drugs Sales Market Share (2012-2017)

Table Merck Basic Information List

Table Merck Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Merck Type 1 Diabetes Drugs Sales Market Share (2012-2017)

Table Perle Biosciences Basic Information List

Table Perle Biosciences Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Perle Biosciences Type 1 Diabetes Drugs Sales Market Share (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Pfizer Type 1 Diabetes Drugs Sales Market Share (2012-2017)

Table Merrion Pharmaceutical Basic Information List

Table Merrion Pharmaceutical Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Merrion Pharmaceutical Type 1 Diabetes Drugs Sales Market Share (2012-2017)

Table Boehringer Ingelheim Basic Information List

Table Boehringer Ingelheim Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Boehringer Ingelheim Type 1 Diabetes Drugs Sales Market Share (2012-2017)

Table XOMA Basic Information List

Table Osiris Therapeutics Basic Information List

Table GlaxoSmithKline Basic Information List

Table Generex Biotechnology Basic Information List

Table Gan & Lee Pharmaceuticals Basic Information List

Table Adocia Basic Information List

Table Baxalta Basic Information List

Table Tolerio Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Type 1 Diabetes Drugs

Figure Manufacturing Process Analysis of Type 1 Diabetes Drugs

Figure Type 1 Diabetes Drugs Industrial Chain Analysis

Table Raw Materials Sources of Type 1 Diabetes Drugs Major Manufacturers in 2015

Table Major Buyers of Type 1 Diabetes Drugs

Table Distributors/Traders List

Figure United States Type 1 Diabetes Drugs Production and Growth Rate Forecast (2017-2022)

Figure United States Type 1 Diabetes Drugs Revenue and Growth Rate Forecast (2017-2022)

Table United States Type 1 Diabetes Drugs Production Forecast by Type (2017-2022)

Table United States Type 1 Diabetes Drugs Consumption Forecast by Application (2017-2022)

Table United States Type 1 Diabetes Drugs Sales Forecast by States (2017-2022)

Table United States Type 1 Diabetes Drugs Sales Share Forecast by States (2017-2022)